Hamed Rania, Awadallah Areeg, Sunoqrot Suhair, Tarawneh Ola, Nazzal Sami, AlBaraghthi Tamadur, Al Sayyad Jihan, Abbas Aiman
Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, P.O. Box 130, Amman, 11733, Jordan.
College of Health and Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, Monroe, Louisiana, 71201, USA.
AAPS PharmSciTech. 2016 Apr;17(2):418-26. doi: 10.1208/s12249-015-0365-2. Epub 2015 Jul 23.
The objective of this study was to investigate the pH-dependent solubility and dissolution of weakly basic Biopharmaceutical Classification Systems (BCS) class II drugs, characterized by low solubility and high permeability, using carvedilol, a weak base with a pK a value of 7.8, as a model drug. A series of solubility and in vitro dissolution studies was carried out using media that simulate the gastric and intestinal fluids and cover the physiological pH range of the GI from 1.2 to 7.8. The effect of ionic strength, buffer capacity, and buffer species of the dissolution media on the solubility and dissolution behavior of carvedilol was also investigated. The study revealed that carvedilol exhibited a typical weak base pH-dependent solubility profile with a high solubility at low pH (545.1-2591.4 μg/mL within the pH range 1.2-5.0) and low solubility at high pH (5.8-51.9 μg/mL within the pH range 6.5-7.8). The dissolution behavior of carvedilol was consistent with the solubility results, where carvedilol release was complete (95.8-98.2% released within 60 min) in media simulating the gastric fluid (pH 1.2-5.0) and relatively low (15.9-86.2% released within 240 min) in media simulating the intestinal fluid (pH 6.5-7.8). It was found that the buffer species of the dissolution media may influence the solubility and consequently the percentage of carvedilol released by forming carvedilol salts of varying solubilities. Carvedilol solubility and dissolution decreased with increasing ionic strength, while lowering the buffer capacity resulted in a decrease in carvedilol solubility and dissolution rate.
本研究的目的是使用卡维地洛(一种pKa值为7.8的弱碱)作为模型药物,研究具有低溶解度和高渗透性特征的弱碱性生物药剂学分类系统(BCS)II类药物的pH依赖性溶解度和溶出度。使用模拟胃液和肠液并覆盖胃肠道生理pH范围(1.2至7.8)的介质进行了一系列溶解度和体外溶出度研究。还研究了溶出介质的离子强度、缓冲容量和缓冲剂种类对卡维地洛溶解度和溶出行为的影响。研究表明,卡维地洛呈现出典型的弱碱pH依赖性溶解度曲线,在低pH值下具有高溶解度(在pH范围1.2至5.0内为545.1 - 2591.4μg/mL),在高pH值下具有低溶解度(在pH范围6.5至7.8内为5.8 - 51.9μg/mL)。卡维地洛的溶出行为与溶解度结果一致,在模拟胃液(pH 1.2 - 5.0)的介质中卡维地洛释放完全(60分钟内释放95.8 - 98.2%),而在模拟肠液(pH 6.5 - 7.8)的介质中相对较低(240分钟内释放15.9 - 86.2%)。发现溶出介质的缓冲剂种类可能通过形成不同溶解度的卡维地洛盐来影响溶解度,进而影响卡维地洛的释放百分比。卡维地洛的溶解度和溶出度随离子强度的增加而降低,而降低缓冲容量会导致卡维地洛溶解度和溶出速率降低。